Clinical importance of antiplatelet drugs in cardiovascular diseases

Area of Science:

• Cardiology
• Pharmacology
• Hematology

Background:

• Platelets are vital for hemostasis and pathological thrombus formation.
• Inhibiting platelet aggregation significantly reduces ischemic atherothrombotic event mortality and morbidity.
• Antiplatelet therapy is a cornerstone in managing cardiovascular, cerebrovascular, and peripheral arterial diseases.

Purpose of the Study:

• To provide an overview of essential antiplatelet drugs.
• To explain their mechanisms of action.
• To discuss their application in cardiovascular diseases and monitoring strategies.

Main Methods:

• Literature review of antiplatelet drugs.
• Analysis of mechanisms of action.
• Discussion of clinical usage and therapeutic monitoring.

Main Results:

• Identified key antiplatelet agents and their roles in preventing atherothrombotic events.
• Detailed mechanisms of platelet inhibition.
• Outlined recommended clinical applications and monitoring approaches.

Conclusions:

• Antiplatelet therapy is a critical intervention for ischemic cardiovascular diseases.
• Understanding drug mechanisms and monitoring effectiveness is essential for optimal patient outcomes.
• Addressing therapeutic failure is key to successful antiplatelet treatment.